|
ZBED4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.754000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.673800E-01 |
| Normal-vs-Stage2 |
2.732000E-01 |
| Normal-vs-Stage3 |
5.260100E-02 |
| Normal-vs-Stage4 |
1.228640E-01 |
| Stage1-vs-Stage2 |
2.389600E-01 |
| Stage1-vs-Stage3 |
9.924900E-03 |
| Stage1-vs-Stage4 |
6.634400E-02 |
| Stage2-vs-Stage3 |
4.870600E-01 |
| Stage2-vs-Stage4 |
7.258600E-01 |
| Stage3-vs-Stage4 |
7.411600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.102400E-01 |
| Normal-vs-AfricanAmerican |
7.026400E-01 |
| Normal-vs-Asian |
5.291600E-01 |
| Caucasian-vs-AfricanAmerican |
4.484000E-01 |
| Caucasian-vs-Asian |
1.911400E-01 |
| AfricanAmerican-vs-Asian |
3.974600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.347620E-01 |
| Normal-vs-Female |
7.789200E-01 |
| Male-vs-Female |
4.199900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.376600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.089000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.262600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.847820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.979200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.146400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.702600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.064600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.575200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.664200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.409400E-01 |
| Normal-vs-Grade 2 |
7.005600E-01 |
| Normal-vs-Grade 3 |
7.341700E-02 |
| Normal-vs-Grade 4 |
1.267380E-01 |
| Grade 1-vs-Grade 2 |
9.034100E-02 |
| Grade 1-vs-Grade 3 |
1.837590E-02 |
| Grade 1-vs-Grade 4 |
1.951780E-02 |
| Grade 2-vs-Grade 3 |
3.525700E-02 |
| Grade 2-vs-Grade 4 |
9.890300E-02 |
| Grade 3-vs-Grade 4 |
9.232800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.852000E-01 |
| Normal-vs-ccB subtype |
1.387630E-01 |
| ccA subtype-vs-ccB subtype |
8.114000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.855030E-01 |
| Normal-vs-N1 |
9.463200E-01 |
| N0-vs-N1 |
4.753400E-01 |
|
|
